Home  »  Business  »  Berkshire Biomedical Awarded Phase II Funding for NIH Research Grant to Support Continued Development of the COPA™ System for Automated at Home Methadone Administration

Berkshire Biomedical Awarded Phase II Funding for NIH Research Grant to Support Continued Development of the COPA™ System for Automated at Home Methadone Administration

Funds from the Two-Phase Fast-Track SBIR Grant, Combined, Total Just Over $2.0 Million DALLAS, Dec. 7, 2022 /PRNewswire/ — Berkshire Biomedical Corporation (“Berkshire” or “the Company”), focused on developing its proprietary, hand-held, automated personalized drug dispensing technology…

About the Author

has written 41541 stories on this site.

«
»
Copyright © 2010 Business and Corporate News.